185 related articles for article (PubMed ID: 36275814)
1. Milder outcomes of SARS-CoV-2 genetically confirmed reinfections compared to primary infections with the delta variant: A retrospective case-control study.
Suljič A; Sočan M; Mrzel M; Lunar MM; Korva M; Štorman A; Prosenc K; Janežič S; Žohar-Čretnik T; Zupanič T; Poljak M; Avšič-Županc T
Front Med (Lausanne); 2022; 9():962653. PubMed ID: 36275814
[TBL] [Abstract][Full Text] [Related]
2. Role of previous infection with SARS-CoV-2 in protecting against omicron reinfections and severe complications of COVID-19 compared to pre-omicron variants: a systematic review.
Arabi M; Al-Najjar Y; Sharma O; Kamal I; Javed A; Gohil HS; Paul P; Al-Khalifa AM; Laws S; Zakaria D
BMC Infect Dis; 2023 Jun; 23(1):432. PubMed ID: 37365490
[TBL] [Abstract][Full Text] [Related]
3. Protection of hybrid immunity against SARS-CoV-2 reinfection and severe COVID-19 during periods of Omicron variant predominance in Mexico.
Montes-González JA; Zaragoza-Jiménez CA; Antonio-Villa NE; Fermín-Martínez CA; Ramírez-García D; Vargas-Vázquez A; Gutiérrez-Vargas RI; García-Rodríguez G; López-Gatell H; Valdés-Ferrer SI; Bello-Chavolla OY
Front Public Health; 2023; 11():1146059. PubMed ID: 37081954
[TBL] [Abstract][Full Text] [Related]
4. Frequency and risk of SARS-CoV-2 reinfections in Norway: a nation-wide study, February 2020 to January 2022.
Bøås H; Storm ML; Tapia G; Kristoffersen AB; Løvlie AL; Størdal K; Lyngstad TM; Bragstad K; Hungnes O; Veneti L
BMC Public Health; 2024 Jan; 24(1):181. PubMed ID: 38225588
[TBL] [Abstract][Full Text] [Related]
5. Risk of SARS-CoV-2 reinfections in children: a prospective national surveillance study between January, 2020, and July, 2021, in England.
Mensah AA; Campbell H; Stowe J; Seghezzo G; Simmons R; Lacy J; Bukasa A; O'Boyle S; Ramsay ME; Brown K; Ladhani SN
Lancet Child Adolesc Health; 2022 Jun; 6(6):384-392. PubMed ID: 35358491
[TBL] [Abstract][Full Text] [Related]
6. Incidence, Risk, and Severity of SARS-CoV-2 Reinfections in Children and Adolescents Between March 2020 and July 2022 in Serbia.
Medic S; Anastassopoulou C; Lozanov-Crvenkovic Z; Dragnic N; Petrovic V; Ristic M; Pustahija T; Tsakris A; Ioannidis JPA
JAMA Netw Open; 2023 Feb; 6(2):e2255779. PubMed ID: 36780157
[TBL] [Abstract][Full Text] [Related]
7. Severe SARS-CoV-2 Breakthrough Reinfection With Delta Variant After Recovery From Breakthrough Infection by Alpha Variant in a Fully Vaccinated Health Worker.
Shastri J; Parikh S; Aggarwal V; Agrawal S; Chatterjee N; Shah R; Devi P; Mehta P; Pandey R
Front Med (Lausanne); 2021; 8():737007. PubMed ID: 34490316
[No Abstract] [Full Text] [Related]
8. Protective effect of a first SARS-CoV-2 infection from reinfection: a matched retrospective cohort study using PCR testing data in England.
Lacy J; Mensah A; Simmons R; Andrews N; Siddiqui MR; Bukasa A; O'Boyle S; Campbell H; Brown K
Epidemiol Infect; 2022 May; 150():e109. PubMed ID: 35607808
[TBL] [Abstract][Full Text] [Related]
9. SARS-CoV-2 infection-induced immunity reduces rates of reinfection and hospitalization caused by the Delta or Omicron variants.
de La Vega MA; Polychronopoulou E; Xiii A; Ding Z; Chen T; Liu Q; Lan J; Nepveu-Traversy ME; Fausther-Bovendo H; Zaidan MF; Wong G; Sharma G; Kobinger GP
Emerg Microbes Infect; 2023 Dec; 12(1):e2169198. PubMed ID: 36655944
[TBL] [Abstract][Full Text] [Related]
10. SARS-CoV-2 incidence, transmission, and reinfection in a rural and an urban setting: results of the PHIRST-C cohort study, South Africa, 2020-21.
Cohen C; Kleynhans J; von Gottberg A; McMorrow ML; Wolter N; Bhiman JN; Moyes J; du Plessis M; Carrim M; Buys A; Martinson NA; Kahn K; Tollman S; Lebina L; Wafawanaka F; du Toit JD; Gómez-Olivé FX; Dawood FS; Mkhencele T; Sun K; Viboud C; Tempia S;
Lancet Infect Dis; 2022 Jun; 22(6):821-834. PubMed ID: 35298900
[TBL] [Abstract][Full Text] [Related]
11. COVID-19 pandemic dynamics in India, the SARS-CoV-2 Delta variant, and implications for vaccination.
Yang W; Shaman J
medRxiv; 2021 Nov; ():. PubMed ID: 34845460
[TBL] [Abstract][Full Text] [Related]
12. Outcomes associated with SARS-CoV-2 reinfection in individuals with natural and hybrid immunity.
Suleyman G; Fadel R; Patel K; Shadid AM; Stuart HBC; Kattula M; Janis A; Maki M; Chao S; Alangaden G; Brar I
J Infect Public Health; 2023 Aug; 16(8):1262-1268. PubMed ID: 37302273
[TBL] [Abstract][Full Text] [Related]
13. Risk and severity of SARS-CoV-2 reinfections during 2020-2022 in Vojvodina, Serbia: A population-level observational study.
Medić S; Anastassopoulou C; Lozanov-Crvenković Z; Vuković V; Dragnić N; Petrović V; Ristić M; Pustahija T; Gojković Z; Tsakris A; Ioannidis JPA
Lancet Reg Health Eur; 2022 Sep; 20():100453. PubMed ID: 35791336
[TBL] [Abstract][Full Text] [Related]
14. SARS-CoV-2 intra-host diversity, antibody response, and disease severity after reinfection by the variant of concern Gamma in Brazil.
Naveca FG; Nascimento VA; Nascimento F; Ogrzewalska M; Pauvolid-Corrêa A; Araújo MF; Arantes I; Batista ÉR; Magalhães AÁ; Vinhal F; Mattos TP; Riediger I; Debur MDC; Grinsztejn B; Veloso VG; Brasil P; Rodrigues RR; Rovaris DB; Fernandes SB; Fernandes C; Santos JHA; Abdalla LF; Costa-Filho R; Silva M; Souza V; Costa ÁA; Mejía M; Brandão MJ; Gonçalves LF; Silva GA; de Jesus MS; Pessoa K; Corado ALG; Duarte DCG; Machado AB; Zukeram KA; Valente N; Lopes RS; Pereira EC; Appolinario LR; Rocha AS; Tort LFL; Sekizuka T; Itokawa K; Hashino M; Kuroda M; Dezordi FZ; Wallau GL; Delatorre E; Gräf T; Siqueira MM; Bello G; Resende PC
Sci Rep; 2023 May; 13(1):7306. PubMed ID: 37147348
[TBL] [Abstract][Full Text] [Related]
15. COVID-19 Cases and Hospitalizations by COVID-19 Vaccination Status and Previous COVID-19 Diagnosis - California and New York, May-November 2021.
León TM; Dorabawila V; Nelson L; Lutterloh E; Bauer UE; Backenson B; Bassett MT; Henry H; Bregman B; Midgley CM; Myers JF; Plumb ID; Reese HE; Zhao R; Briggs-Hagen M; Hoefer D; Watt JP; Silk BJ; Jain S; Rosenberg ES
MMWR Morb Mortal Wkly Rep; 2022 Jan; 71(4):125-131. PubMed ID: 35085222
[TBL] [Abstract][Full Text] [Related]
16. Mild reinfection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Delta variant: First case report from Indonesia.
Isnaini N; Mardian Y; Lokida D; Budiono F; Butar-Butar DP; Arlinda D; Salim G; Kosasih H; Wulan WN; Perodin J; Neal A; Lane HC; Karyana M
Front Med (Lausanne); 2022; 9():906469. PubMed ID: 35935779
[TBL] [Abstract][Full Text] [Related]
17. COVID-19 Reinfection Has Better Outcomes Than the First Infection in Solid Organ Transplant Recipients.
Solera JT; Árbol BG; Mittal A; Hall VG; Marinelli T; Bahinskaya I; Humar A; Kumar D
Transplantation; 2024 May; 108(5):1249-1256. PubMed ID: 38291585
[TBL] [Abstract][Full Text] [Related]
18. COVID-19 reinfections in Mexico City: implications for public health.
de Anda-Jáuregui G; Gómez-Romero L; Cañas S; Campos-Romero A; Alcántar-Fernández J; Cedro-Tanda A
Front Public Health; 2023; 11():1321283. PubMed ID: 38419814
[TBL] [Abstract][Full Text] [Related]
19. Reinfection with new variants of SARS-CoV-2 after natural infection: a prospective observational cohort in 13 care homes in England.
Jeffery-Smith A; Rowland TAJ; Patel M; Whitaker H; Iyanger N; Williams SV; Giddings R; Thompson L; Zavala M; Aiano F; Ellis J; Lackenby A; Höschler K; Brown K; Ramsay ME; Gopal R; Chow JY; Ladhani SN; Zambon M
Lancet Healthy Longev; 2021 Dec; 2(12):e811-e819. PubMed ID: 34873592
[TBL] [Abstract][Full Text] [Related]
20. Observed protection against SARS-CoV-2 reinfection following a primary infection: A Danish cohort study among unvaccinated using two years of nationwide PCR-test data.
Michlmayr D; Hansen CH; Gubbels SM; Valentiner-Branth P; Bager P; Obel N; Drewes B; Møller CH; Møller FT; Legarth R; Mølbak K; Ethelberg S
Lancet Reg Health Eur; 2022 Sep; 20():100452. PubMed ID: 35791335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
